DK163235C - Analogifremgangsmaade til fremstilling af farmaceutisk aktive 3-hydroxysmoersyresalte - Google Patents

Analogifremgangsmaade til fremstilling af farmaceutisk aktive 3-hydroxysmoersyresalte

Info

Publication number
DK163235C
DK163235C DK081583A DK81583A DK163235C DK 163235 C DK163235 C DK 163235C DK 081583 A DK081583 A DK 081583A DK 81583 A DK81583 A DK 81583A DK 163235 C DK163235 C DK 163235C
Authority
DK
Denmark
Prior art keywords
analogue
preparation
acid salts
pharmaceutical active
hydroxylic acid
Prior art date
Application number
DK081583A
Other languages
Danish (da)
English (en)
Other versions
DK81583A (da
DK163235B (da
DK81583D0 (da
Inventor
Jacques Lammerant
Jaroslaw Kolanowski
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of DK81583D0 publication Critical patent/DK81583D0/da
Publication of DK81583A publication Critical patent/DK81583A/da
Publication of DK163235B publication Critical patent/DK163235B/da
Application granted granted Critical
Publication of DK163235C publication Critical patent/DK163235C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK081583A 1982-02-23 1983-02-23 Analogifremgangsmaade til fremstilling af farmaceutisk aktive 3-hydroxysmoersyresalte DK163235C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8203100A FR2521857B1 (fr) 1982-02-23 1982-02-23 Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
FR8203100 1982-02-23

Publications (4)

Publication Number Publication Date
DK81583D0 DK81583D0 (da) 1983-02-23
DK81583A DK81583A (da) 1983-08-24
DK163235B DK163235B (da) 1992-02-10
DK163235C true DK163235C (da) 1992-06-29

Family

ID=9271331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK081583A DK163235C (da) 1982-02-23 1983-02-23 Analogifremgangsmaade til fremstilling af farmaceutisk aktive 3-hydroxysmoersyresalte

Country Status (21)

Country Link
US (2) US4579955A (enExample)
EP (1) EP0087192B1 (enExample)
JP (1) JPS58201746A (enExample)
KR (1) KR910000143B1 (enExample)
AT (1) ATE24478T1 (enExample)
AU (2) AU560757B2 (enExample)
CA (1) CA1203242A (enExample)
DE (1) DE3368601D1 (enExample)
DK (1) DK163235C (enExample)
ES (2) ES8500240A1 (enExample)
FI (1) FI79523C (enExample)
FR (1) FR2521857B1 (enExample)
GR (1) GR77934B (enExample)
IE (1) IE54561B1 (enExample)
IL (1) IL67965A0 (enExample)
MX (1) MX156855A (enExample)
NO (1) NO161909C (enExample)
NZ (1) NZ203279A (enExample)
PH (1) PH21561A (enExample)
PT (1) PT76267A (enExample)
ZA (1) ZA831019B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
USRE38604E1 (en) 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
BE1001209A3 (fr) * 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
DE4113984C2 (de) * 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salze der 4-Hydroxy-Buttersäure
ES2051222B1 (es) * 1992-03-12 1995-02-16 Sanmiguel Gabriel Serrano Procedimiento de neutralizacion de acido alfa-hidroxietanoico.
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
CA2283642C (en) * 1997-03-17 2012-05-15 Btg International Limited Therapeutic compositions
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6613356B1 (en) 2000-10-10 2003-09-02 Victor Vlahakos Weight loss medication and method
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
WO2006020137A2 (en) * 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
WO2006020179A2 (en) * 2004-07-20 2006-02-23 Ketocytonyx Inc. Oligomeric ketone compounds
EP1778212A4 (en) * 2004-07-23 2010-12-08 Btg Int Ltd SACCHARIDES CETOGENES
US20070197645A1 (en) * 2004-09-21 2007-08-23 Martin Keith F Treatment of adhd
ES2574557T3 (es) * 2004-09-21 2016-06-20 Btg International Limited Miméticos dopaminérgicos
RU2302239C1 (ru) * 2006-07-14 2007-07-10 Михаил Владимирович Покровский Способ фармакологической коррекции ишемии конечности
JPWO2008053982A1 (ja) 2006-10-30 2010-02-25 株式会社オフテクス アレルギー治療用組成物
DK2914251T3 (da) 2012-11-05 2019-11-04 Us Health Ketonlegemer til beskyttelse af væv mod beskadigelse som følge af ioniseringsstråling
KR20180088809A (ko) 2015-11-19 2018-08-07 가부시키가이샤 오츠카 세이야쿠 코죠 3-히드록시이소발레르산의 1가 양이온염의 결정 및 그 결정의 제조 방법
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
JP6710098B2 (ja) * 2016-05-10 2020-06-17 大阪瓦斯株式会社 栄養剤組成物及び栄養補助食品
US11098007B2 (en) 2016-06-24 2021-08-24 Kyowa Hakko Bio Co., Ltd. Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
CN112341331B (zh) * 2019-08-07 2023-04-07 辽宁科硕营养科技股份有限公司 一种3-羟基丁酸盐及其制备方法与应用
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
WO2024192165A1 (en) * 2023-03-14 2024-09-19 The Board Of Trustees Of The Leland Stanford Junior University N-beta-hydroxybutyryl-amino acids and related compositions and methods
WO2025056246A1 (en) * 2023-09-11 2025-03-20 Societe Des Produits Nestle S.A. Polymorphs and compositions comprising same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101097A (en) * 1934-07-26 1937-12-07 Wm S Merrell Co Products for rendering the urine bacteriostatic
US2799684A (en) * 1954-06-18 1957-07-16 Food Chemical And Res Lab Inc Crystalline compounds of tryptophane and methods of manufacturing them
NL279760A (enExample) * 1961-06-17
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
DE2733202A1 (de) * 1976-08-04 1978-02-09 Agroferm Ag Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4412943A (en) * 1981-02-23 1983-11-01 Kao Soap Co., Ltd. Liquid detergent composition
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Also Published As

Publication number Publication date
PT76267A (fr) 1983-03-01
CA1203242A (fr) 1986-04-15
GR77934B (enExample) 1984-09-25
AU1162483A (en) 1983-09-01
US4771074A (en) 1988-09-13
MX156855A (es) 1988-10-07
DK81583A (da) 1983-08-24
EP0087192A1 (fr) 1983-08-31
DK163235B (da) 1992-02-10
ES519991A0 (es) 1984-10-01
ATE24478T1 (de) 1987-01-15
ES8500240A1 (es) 1984-10-01
KR910000143B1 (ko) 1991-01-21
FI79523C (fi) 1990-01-10
ZA831019B (en) 1983-11-30
DE3368601D1 (en) 1987-02-05
NO161909C (no) 1989-10-11
ES8506283A1 (es) 1985-07-01
AU6916187A (en) 1987-05-21
AU602329B2 (en) 1990-10-11
IE830366L (en) 1983-08-23
PH21561A (en) 1987-12-11
JPS58201746A (ja) 1983-11-24
DK81583D0 (da) 1983-02-23
IL67965A0 (en) 1983-06-15
FR2521857B1 (fr) 1985-10-31
FI830603A0 (fi) 1983-02-23
ES532880A0 (es) 1985-07-01
IE54561B1 (en) 1989-11-22
KR840003414A (ko) 1984-09-08
EP0087192B1 (fr) 1986-12-30
US4579955A (en) 1986-04-01
FI830603L (fi) 1983-08-24
AU560757B2 (en) 1987-04-16
FI79523B (fi) 1989-09-29
FR2521857A1 (fr) 1983-08-26
NZ203279A (en) 1985-04-30
NO830618L (no) 1983-08-24
NO161909B (no) 1989-07-03

Similar Documents

Publication Publication Date Title
DK163235C (da) Analogifremgangsmaade til fremstilling af farmaceutisk aktive 3-hydroxysmoersyresalte
DK165988C (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
DK160614C (da) Analogifremgangsmaade til fremstilling af vinblastinderivater og farmaceutisk acceptable salte deraf
FI883739A0 (fi) Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi
NO1994011I1 (no) Cisaprid
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
CY1105381T1 (el) Αλατα βορονικου οξεως
ES8801310A1 (es) Un procedimiento para preparar derivados de alanil-protina.
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
NZ302072A (en) 1,3-diamino propyl stereomeric derivatives and organic acid and inorganic salts of their amine intermediates in the preparation of retroviral protease inhibitors
PT92558A (pt) Processo para a preparacao de derivados de aminoacidos inibidores de enzimas e de composicoes farmaceuticas que os contem
ATA363479A (de) Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
DK160316C (da) Analogifremgangsmaade til fremstilling af beta-casomorphinanaloge peptider samt pharmakologisk acceptable syreadditionssalte og metalkomplekser deraf
NO874109L (no) Salicylsyreamider, fremgangsmaate til deres fremstilling og deres anvendelse.
SE8502315L (sv) Forbettrat transamineringsforfarande for framstellning av aminosyror
DK0717048T3 (da) Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE68919301D1 (de) Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS.
FI884634L (fi) Syklopropyylimalonianilaattijohdannaisia sekä tällaista johdannaista sisältävä koostumus käytettäväksi kasvien kasvun hidastamiseksi
ES8704185A1 (es) Procedimiento para preparar derivados de aminoacidos

Legal Events

Date Code Title Description
PBP Patent lapsed